Use of Glucagon-Like Peptide-1 Receptor Agonists in Danish Adolescents and Young Adults 2018-2025
Listen to this summary
The authors aimed to examine the trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) among Danish adolescents and young adults aged 12 to 24 from 2018 to 2025. They found a significant increase in GLP-1RA prescriptions, particularly among those aged 18-24, with a notable prevalence of psychiatric comorbidities among users. The study highlights the rapid uptake of these medications and underscores the need for ongoing evaluation of their long-term safety and mental health implications in this demographic.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Obesity (Silver Spring, Md.)
View all →More in Pediatrics
View all →Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · Pediatric nephrology (Berlin, Germany)
IPNA clinical practice recommendations for the management of aHUS and secondary TMA in children
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


